Drug interactions
Eslicarbazepine + Paclitaxel protein bound
Severity: Minor
Eslicarbazepine and Paclitaxel protein bound: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Paclitaxel is cleared partly through CYP3A4 and CYP2C8. Weak CYP3A4 induction by eslicarbazepine might slightly reduce paclitaxel exposure and its efficacy, though the effect is expected to be small.
What this interaction means in plain words
Eslicarbazepine and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Weak induction of CYP3A4 by eslicarbazepine may increase paclitaxel metabolism.
What to do
No empirical dose change is needed. Monitor oncologic response and toxicity, and consider a non-inducing antiseizure drug if reduced efficacy is a concern.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Paclitaxel protein bound, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Eslicarbazepine
- Eslicarbazepine + Mavacamten Contraindicated
- Eslicarbazepine + Rilpivirine Contraindicated
- Artemether / lumefantrine + Eslicarbazepine Major
- Avapritinib + Eslicarbazepine Major
- Bedaquiline + Eslicarbazepine Major
- Benzhydrocodone / acetaminophen + Eslicarbazepine Major
Frequently asked questions
Can I take Eslicarbazepine with Paclitaxel protein bound?
MediHelp rates the interaction as minor. Eslicarbazepine and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Paclitaxel is cleared partly through CYP3A4 and CYP2C8. Weak CYP3A4 induction by eslicarbazepine might slightly reduce paclitaxel exposure and its efficacy, though the effect is expected to be small.
How serious is the interaction between Eslicarbazepine and Paclitaxel protein bound?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed. Monitor oncologic response and toxicity, and consider a non-inducing antiseizure drug if reduced efficacy is a concern.
What other medicines interact with Eslicarbazepine?
MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
